companies

Qubit Pharmaceuticals

Founded 2020
Employees 40+
Primary contact
29, rue du Faubourg Saint Jacques
75014 Paris
France
Links
https://www.qubit-pharmaceuticals.com/
Diseases & Conditions
Sections
Technologies
Qubit Pharmaceuticals aims to speed up the lengthy and costly drug discovery process, where potential drugs are screened from a very large number of molecules. It increases the accuracy of these calculations by leveraging the power of its own 200 GPU supercomputer, called Gaia, developed in partnership with Nvidia. Qubit's software, called Atlas, has been demonstrated to have significantly higher accuracy than other approaches with multiple candidates in its pipeline in oncology. In addition to its Paris headquarters, the company has an office in Boston.
Founded 2020
Employees 40+
Primary contact
29, rue du Faubourg Saint Jacques
75014 Paris
France
Links
https://www.qubit-pharmaceuticals.com/
Diseases & Conditions
Sections
Technologies

Funding 💰

Total $25M
Select investors European Innovation Council, XAnge, Quantonation, Omnes Capital, Bpifrance, EIT Health

Key people 🧑‍🤝‍🧑

Highlights ⭐

  • Decades in the making: Qubit's proprietary technologies, the fruit of over 30 years of research, make it possible to develop novel drug candidates and innovative modes of action against targets previously considered too complex.
  • Atlas: Qubit's ultra-high resolution drug design platform, which enables drug hunters to discover, optimize and validate drug candidates and carry out complex computations at scale, on any hardware, whether on-premises or on the cloud.
  • Gaia: The company's 200 GPU supercomputer, created in collaboration with Nvidia. It offers 1,000+ nanoseconds of MD simulation per day with polarizable force fields, over 50 PetaFLOPS AI dedicated to advanced chemical space exploration, and 30+ qubits.

Awards & Recognitions 🏆

  • 2022 Hyperion Research: HPC Innovation Excellence Award 🔗
Last update: June 3, 2023